德诺苏马布降低了二次性甲状腺功能过强和骨质较低的透析患者的心上脂肪组织衰减
Chien-Liang Chen1,2,3,4,5, En-Shao Liou4,5,6, Ming-Ting Wu4,5,7
1Faculty of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
Cardiorenal medicine
|February 7, 2024
概括
在患有二次性副甲状腺功能障碍的透析患者中,德诺苏马布治疗可能会减少心上脂肪组织衰减和减缓冠状动脉化进展. 这为这种高风险人群提供了潜在的心血管益处.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
背景情况:
- 骨质保护素模仿剂denosumab是治疗副甲状腺功能障碍症的一个选择,当副甲状腺切除术是不可行的.
- 药物的潜在心血管作用是由其对心上脂肪组织 (EAT) 和冠状动脉化 (CAC) 的影响所暗示的.
- 二次性偏甲状腺症 (SHPT) 在透析患者中很常见,并与心血管并发症有关.
研究的目的:
- 为了研究德诺苏马布对EAT减弱 (EATat) 和CAC在患有SHPT的透析患者的影响.
- 为了比较透析患者与没有denosumab治疗的心血管标志物.
主要方法:
- 一项涉及SHPT透析患者的队列研究.
- 透析和倾向得分之间的基线特征的比较与非透析患者的匹配得分.
- 计算机断层扫描 (CT) 扫描在基线和6个月后对透析患者进行了随访 (n=24与denosumab,n=21没有).
主要成果:
- 与非透析患者相比,透析患者的基线EATat和CAC较高.
- 在没有denosumab的情况下,透析患者在6个月内显示CAC增加,而EATat.没有显著变化.
- 接受德诺苏马布透析的透析患者表现出EATat显著下降,而CAC进展没有显著改变.
结论:
- 德诺苏马布治疗可能会导致心表脂肪组织衰减的减少.
- 德诺苏马布可能会减缓冠状动脉化在透析患者的进展.
- 这些发现表明,在这个患者群体中,德诺苏马布可能具有心血管保护作用.
相关概念视频
01:17Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
01:40Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
01:31Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
00:59The Parathyroid Glands
2.1K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
2.1K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:21Skeleton and Calcium Homeostasis
4.5K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.5K